13.10.2025
opracowała: dr n. med. Martyna Biała
Na podstawie: Taniguchi J., Aso S., Matsui H, i wsp.: Outcomes of ceftriaxone 2 g versus 1 g daily in hospitalized patients with pneumonia: a nationwide retrospective cohort study. J. Antimicrob. Chemother. 2025 Aug 1; 80(8): 2194–2202. doi: 10.1093/jac/dkaf189.